Lyon; David Keith

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lyon; David Keith.The latest application filed is for "compositions and methods for the treatment of neurodegenerative and other diseases".

Company Profile

0.16.24

Lyon; David Keith - Bend OR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for the treatment of neurodegenerative and other diseases Grant 10,398,713 - Reeder , et al. Sep	2019-09-03
Compositions and Methods for the Treatment of Neurodegenerative and Other Diseases App 20190015431 - Reeder; Thaddeus Cromwell ; et al.	2019-01-17
Compositions and methods for the treatment of neurodegenerative and other diseases Grant 9,980,978 - Reeder , et al. May 29, 2	2018-05-29
Compositions and methods for the treatment of neurodegenerative and other diseases Grant 9,974,798 - Reeder , et al. May 22, 2	2018-05-22
Compositions and methods for the treatment of neurodegenerative and other diseases Grant 9,918,997 - Reeder , et al. March 20, 2	2018-03-20
Compositions and Methods for the Treatment of Neurodegenerative and Other Diseases App 20170165279 - Reeder; Thaddeus Cromwell ; et al.	2017-06-15
Compositions And Methods For The Treatment Of Neurodegenerative And Other Diseases App 20170079991 - Reeder; Thaddeus Cromwell ; et al.	2017-03-23
Compositions And Methods For The Treatment Of Neurodegenerative And Other Diseases App 20170079990 - Reeder; Thaddeus Cromwell ; et al.	2017-03-23
Compositions and methods for the treatment of neurodegenerative and other diseases Grant 9,597,339 - Reeder , et al. March 21, 2	2017-03-21
Pharmaceutical compositions with enhanced performance Grant 8,940,800 - Babcock , et al. January 27, 2	2015-01-27
Drying of drug-containing particles Grant 8,834,929 - Dobry , et al. September 16, 2	2014-09-16
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase Grant 8,828,438 - Friesen , et al. September 9, 2	2014-09-09
Compositions and Methods for the Treatment of Neurodegenerative and Other Diseases App 20140221321 - Reeder; Thaddeus Cromwell ; et al.	2014-08-07
Spray dried formulation Grant 8,372,836 - Ketner , et al. February 12, 2	2013-02-12
Pharmaceutical Compositions With Enhanced Performance App 20120264833 - Babcock; Walter C. ; et al.	2012-10-18
Pharmaceutical compositions with enhanced performance Grant 8,207,232 - Babcock , et al. June 26, 2	2012-06-26
Multiparticulates Comprising Low-solubility Drugs And Carriers That Result In Rapid Drug Release App 20110027372 - Appel; Leah Elizabeth ; et al.	2011-02-03
Methods, Dosage Forms And Kits For Administering Ziprasidone Without Food App 20110002989 - Curatolo; William John ; et al.	2011-01-06
Drying Of Drug-containing Particles App 20100028440 - Dobry; Daniel Elmont ; et al.	2010-02-04
Spray dried formulation App 20100029667 - Ketner; Rodney James ; et al.	2010-02-04
Sustained Release Dosage Forms Of Ziprasidone App 20100003331 - Ahmed; Imran ; et al.	2010-01-07
Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release App 20090142401 - Appel; Leah Elizabeth ; et al.	2009-06-04
Pharmaceutical Compositions Of Cholesteryl Ester Transfer Protein Inhibitors And Hmg-Coa Reductase App 20090118328 - Friesen; Dwayne Thomas ; et al.	2009-05-07
Pharmaceutical Compositions With Enhanced Performance App 20080262107 - Babcock; Walter C. ; et al.	2008-10-23
Taste Making Formulation Comprising The Drug In A Dissolution-Retarded Form And/Or Cyclodextrin In A Dissolution-Enhanced Form App 20080075784 - Friesen; Dwayne Thomas ; et al.	2008-03-27
Azithromycin Dosage Forms With Reduced Side Effects App 20080015343 - Hagen; Timothy A. ; et al.	2008-01-17
Sustained release dosage forms of ziprasidone App 20070190129 - Ahmed; Imran ; et al.	2007-08-16
Azithromycin dosage forms with reduced side effects App 20060039988 - Hagen; Timothy A. ; et al.	2006-02-23
Azithromycin dosage forms with reduced side effects App 20060029677 - Hagen; Timothy A. ; et al.	2006-02-09
Azithromycin dosage forms with reduced side effects Grant 6,984,403 - Hagen , et al. January 10, 2	2006-01-10
Compositions comprising an HIV protease inhibitor App 20050129772 - Smith, Scott Wendell ; et al.	2005-06-16
Azithromycin dosage forms with reduced side effects App 20050123627 - Hagen, Timothy A. ; et al.	2005-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.